PB1033 Delphi Consensus Recommendations for Neuraxial Anesthesia in Adults with Platelet Disorders and Coagulation Defects

Autor: Peterson, W., Martin, R., Arnold, D., Carvalho, B., Cuker, A., Provan, D., Rydz, N., Shore, E., Kuter, D., Kouides, P., Lavin, M., James, P., Engen, D., Sholzberg, M.

Publikováno v: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2

GENETIC AND NON-GENETIC DETERMINANTS OF SUCCESSFUL IMMUNE TOLERANCE INDUCTION IN PEOPLE WITH SEVERE HEMOPHILIA A

Autor: Oomen, I, Camelo, RM, Carcao, M, Castaman, G, Eikenboom, JCJ, Fischer, K, Frank Leebeek, WG, Lillicrap, D, Mancuso, ME, Matino, D, Di Minno, DMN, Mohseny, AB, Oldenburg, J, Rezende, SM, Rivard, GE, Rydz, N, Schols, S, Jan, Voorberg, Callado, FMRA, Carvalho, LEM, Franco, VKB, Lorenzato, CS, Fijnvandraat, K, Gouw, S

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S562-S563

Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.

Autor: Rydz, N.¹, Grabell, J.², Lillicrap, D.¹, James, P. D.²

Publikováno v: Haemophilia. Sep2015, Vol. 21 Issue 5, p636-641. 6p. 2 Charts, 2 Graphs.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A

Autor: Pandey, GS, Yanover, C, Miller-Jenkins, LM, Garfield, S, Cole, SA, Curran, JE, Moses, EK, Rydz, N, Simhadri, V, Kimchi-Sarfaty, C, Lillicrap, D, Viel, KR, Przytycka, TM, Pierce, GF, Howard, TE, Sauna, ZE, Lusher, J, Chitlur, M, Ameri, A, Natarajan, K, Iyer, RV, Thompson, AA, Watts, RG, Kempton, CL, Kessler, C, Barrett, JC, Martin, EJ, Key, N, Kruse-Jarres, R, Lessinger, C, Pratt, KP, Josephson, N, McRedmond, K, Withycombe, J, Walsh, C, Matthews, D, Mahlangu, J, Krause, A, Schwyzer, R, Thejpal, R, Rapiti, N, Goga, Y, Coetzee, M, Stones, D, Mann, K, Butenas, S, Almasy, L, Blangero, J, Carless, M, Raja, R, Reed, E

Publikováno v: Pandey, GS; Yanover, C; Miller-Jenkins, LM; Garfield, S; Cole, SA; Curran, JE; et al.(2013). Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A. Nature Medicine, 19(10), 1318-1324. doi: 10.1038/nm.3270. UCSF: Retrieved from: http://www.escholarship.org/uc/item/17x2x1k8

Neutralizing antibodies (inhibitors) to replacement factor VIII (FVIII, either plasma derived or recombinant) impair the effective management of hemophilia A. Individuals with hemophilia A due to major deletions of the FVIII gene (F8) lack antigenica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::4b8311dd7fc1de6def818caf0d91b00f
http://www.escholarship.org/uc/item/17x2x1k8